EDITORIALS

Carboplatin Equals Cisplatin: But How Do I Prescribe It?

Martin Gore

JCO Sep 1 2003: 3183–3185. First published on Jul 14 2003; 10.1200/JCO.2003.06.077. [Full Text] [PDF]

Aggressive Treatment for the Fit Elderly With Non–Small-Cell Lung Cancer? Yes!

Lecia V. Sequist and Thomas J. Lynch

JCO Sep 1 2003: 3186–3188. First published on Jul 21 2003; 10.1200/JCO.2003.04.002. [Full Text] [PDF]

Paris and New York: More in Common Than You Think!

Hyman B. Muss

JCO Sep 1 2003: 3189–3190. First published on Jul 21 2003; 10.1200/JCO.2003.05.082. [Full Text] [PDF]

Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware

Stacy Gray and Olufunmilayo I. Olopade

JCO Sep 1 2003: 3191–3193. First published on Jul 21 2003; 10.1200/JCO.2003.12.069. [Full Text] [PDF]

ORIGINAL REPORTS
Gynecologic Cancer
	Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
	Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel Clarke-Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, and Rebecca Baergen
	JCO Sep 1 2003: 3194–3200. First published on Jul 14 2003; 10.1200/JCO.2003.02.153. [Abstract] [Full Text] [PDF]

Lung Cancer
	The Outcome of Combined-Modality Therapy for Stage III Non–Small-Cell Lung Cancer in the Elderly
	Steven E. Schild, Philip J. Stella, Susan M. Geyer, James A. Bonner, William L. McGinnis, James A. Mailliard, Jeffery Brindle, Aminah Jatoi, and James R. Jett
	JCO Sep 1 2003: 3201–3206. First published on Jul 21 2003; 10.1200/JCO.2003.12.019. [Abstract] [Full Text] [PDF]
	Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial
	V. Alberola, C. Camps, M. Provencio, D. Isla, R. Rosell, C. Vadell, I. Bover, A. Ruiz-Casado, P. Azagra, U. Jiménez, J.L. González-Larriba, P. Diz, F. Cardenal, A. Artal, A. Carrato, S. Morales, J.J. Sánchez, R. de las Peñas, E. Felip, and G. López-Vivanco
	JCO Sep 1 2003: 3207–3213. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Are Older French Patients As Willing As Older American Patients to Undertake Chemotherapy?
	Martine Extermann, Gilles Albrand, Hongbin Chen, Sylvie Zanetta, Ronald Schonwetter, Gilbert B. Zulian, Alan Cantor, and Jean-Pierre Droz
	JCO Sep 1 2003: 3214–3219. First published on Jul 21 2003; 10.1200/JCO.2003.08.091. [Abstract] [Full Text] [PDF]
	Identifying Psychosocial Risk Indicative of Subsequent Resource Use in Families of Newly Diagnosed Pediatric Oncology Patients
	Anne E. Kazak, M. Catherine Cant, Merritt M. Jensen, Mary McSherry, Mary T. Rourke, Wei-Ting Hwang, Melissa A. Alderfer, David Beele, Steven Simms, and Beverly J. Lange
	JCO Sep 1 2003: 3220–3225. [Abstract] [Full Text] [PDF]

Tumor Biology
	ras Mutations Are Associated With Aggressive Tumor Phenotypes and Poor Prognosis in Thyroid Cancer
	Ginesa Garcia-Rostan, Hongyu Zhao, Robert L. Camp, Marina Pollan, Agustin Herrero, Javier Pardo, Ran Wu, Maria Luisa Carcangiu, Jose Costa, and Giovanni Tallini
	JCO Sep 1 2003: 3226–3235. [Abstract] [Full Text] [PDF]
	TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies
	Virginia G. Kaklamani, Nanjiang Hou, Yiansong Bian, Jennifer Reich, Kenneth Offit, Loren S. Michel, W.S. Rubinstein, Alfred Rademaker, and Boris Pasche
	JCO Sep 1 2003: 3236–3243. [Abstract] [Full Text] [PDF]

Breast Cancer
	Changes in the 2003 American Joint Committee on Cancer Staging for Breast Cancer Dramatically Affect Stage-Specific Survival
	Wendy A. Woodward, Eric A. Strom, Susan L. Tucker, Marsha D. McNeese, George H. Perkins, Naomi R. Schechter, S. Eva Singletary, Richard L. Theriault, Gabriel N. Hortobagyi, Kelly K. Hunt, and Thomas A. Buchholz
	JCO Sep 1 2003: 3244–3248. [Abstract] [Full Text] [PDF]
	Phase II Study of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Patients With Metastatic Breast Cancer
	Edgardo Rivera, Vicente Valero, Banu Arun, Melanie Royce, Rosni Adinin, Karen Hoelzer, Ronald Walters, James L. Wade, III, Lajos Pusztai, and Gabriel N. Hortobagyi
	JCO Sep 1 2003: 3249–3254. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Long-Term Neurologic and Neurosensory Sequelae in Adult Survivors of a Childhood Brain Tumor: Childhood Cancer Survivor Study
	Roger J. Packer, James G. Gurney, Judy A. Punyko, Sarah S. Donaldson, Peter D. Inskip, Marilyn Stovall, Yutaka Yasui, Ann C. Mertens, Charles A. Sklar, H. Stacy Nicholson, Lonnie K. Zeltzer, Joseph P. Neglia, and Leslie L. Robison
	JCO Sep 1 2003: 3255–3261. [Abstract] [Full Text] [PDF]
	Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia
	M.L. Den Boer, D.O. Harms, R. Pieters, K.M. Kazemier, U. Göbel, D. Körholz, U. Graubner, R.J. Haas, N. Jorch, H.J. Spaar, G.J.L. Kaspers, W.A. Kamps, A. Van der Does-Van den Berg, E.R. Van Wering, A.J.P. Veerman, and G.E. Janka-Schaub
	JCO Sep 1 2003: 3262–3268. [Abstract] [Full Text] [PDF]
	Older Age Is an Adverse Prognostic Factor in Stage I, Favorable Histology Wilms’ Tumor Treated With Vincristine Monochemotherapy: A Study by the United Kingdom Children’s Cancer Study Group, Wilm’s Tumor Working Group
	K. Pritchard-Jones, A. Kelsey, G. Vujanic, J. Imeson, C. Hutton, and C. Mitchell
	JCO Sep 1 2003: 3269–3275. [Abstract] [Full Text] [PDF]

Neurooncology
	Neuro-Oncology Working Group 01 Trial of Nimustine Plus Teniposide Versus Nimustine Plus Cytarabine Chemotherapy in Addition to Involved-Field Radiotherapy in the First-Line Treatment of Malignant Glioma
	The Neuro-Oncology Working Group of the German Cancer Society
	JCO Sep 1 2003: 3276–3284. [Abstract] [Full Text] [PDF]
	New Classification Scheme for the Prognostic Stratification of Meningioma on the Basis of Chromosome 14 Abnormalities, Patient Age, and Tumor Histopathology
	Angel Maíllo, Alberto Orfao, José María Sayagués, Pedro Díaz, Juan Antonio Gómez-Moreta, Marcelino Caballero, David Santamarta, Angel Santos-Briz, Francisco Morales, and María Dolores Tabernero
	JCO Sep 1 2003: 3285–3295. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
	M.J. Moore, J. Hamm, J. Dancey, P.D. Eisenberg, M. Dagenais, A. Fields, K. Hagan, B. Greenberg, B. Colwell, B. Zee, D. Tu, J. Ottaway, R. Humphrey, and L. Seymour
	JCO Sep 1 2003: 3296–3302. [Abstract] [Full Text] [PDF]
	Phase I/II Study of Hepatic Arterial Therapy With Floxuridine and Dexamethasone in Combination With Intravenous Irinotecan As Adjuvant Treatment After Resection of Hepatic Metastases From Colorectal Cancer
	N. Kemeny, W. Jarnagin, M. Gonen, J. Stockman, L. Blumgart, D. Sperber, A. Hummer, and Y. Fong
	JCO Sep 1 2003: 3303–3309. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor Masses
	Jan Oldenburg, G. Cecilie Alfsen, Hans H. Lien, Nina Aass, Håkon Wæhre, and Sophie D. Fosså
	JCO Sep 1 2003: 3310–3317. [Abstract] [Full Text] [PDF]
	Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer?
	Shabbir M.H. Alibhai, Gary Naglie, Robert Nam, John Trachtenberg, and Murray D. Krahn
	JCO Sep 1 2003: 3318–3327. [Abstract] [Full Text] [PDF]
	Loss of p16 Expression Is of Prognostic Significance in Locally Advanced Prostate Cancer: An Analysis From the Radiation Therapy Oncology Group Protocol 86–10
	A. Chakravarti, K. Heydon, C.L. Wu, E. Hammond, A. Pollack, M. Roach, H. Wolkov, P. Okunieff, J. Cox, J. Fontanesi, R. Abrams, M. Pilepich, and W. Shipley
	JCO Sep 1 2003: 3328–3334. [Abstract] [Full Text] [PDF]
	Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain
	D.S. Ernst, I.F. Tannock, E.W. Winquist, P.M. Venner, L. Reyno, M.J. Moore, K. Chi, K. Ding, C. Elliott, and W. Parulekar
	JCO Sep 1 2003: 3335–3342. [Abstract] [Full Text] [PDF]

Melanoma
	Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma
	Robert Soiffer, F. Stephen Hodi, Frank Haluska, Ken Jung, Silke Gillessen, Samuel Singer, Kenneth Tanabe, Rosemary Duda, Steven Mentzer, Michael Jaklitsch, Raphael Bueno, Shirley Clift, Steve Hardy, Donna Neuberg, Richard Mulligan, Iain Webb, Martin Mihm, and Glenn Dranoff
	JCO Sep 1 2003: 3343–3350. [Abstract] [Full Text] [PDF]
	Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma
	Wen-Jen Hwu, Susan E. Krown, Jennifer H. Menell, Katherine S. Panageas, Janene Merrell, Lynne A. Lamb, Linda J. Williams, Carolyn J. Quinn, Theresa Foster, Paul B. Chapman, Philip O. Livingston, Jedd D. Wolchok, and Alan N. Houghton
	JCO Sep 1 2003: 3351–3356. [Abstract] [Full Text] [PDF]

SPECIAL ARTICLES
	Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
	Aron Goldhirsch, William C. Wood, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, and Hans-Jörg Senn
	JCO Sep 1 2003: 3357–3365. First published on Jul 7 2003; 10.1200/JCO.2003.04.576. [Abstract] [Full Text] [PDF]

ART OF ONCOLOGY

Taking Time

David N. Korones

JCO Sep 1 2003: 3366–3367. [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Locations of Involvement by Malignancies: CASE 1. TESTICULAR PLASMACYTOMA

Atif Shafqat, Moo-Nahm Yum, Rafat Abanour, and Kristen N. Ganjoo

JCO Sep 1 2003: 3368–3369. [Full Text] [PDF]

Unusual Locations of Involvement by Malignancies: CASE 2. METASTATIC PHEOCHROMOCYTOMA TO THE COLON

H. Padmanabhan, L.D. Ehrlich, M. Quazedo, T. Fojo, A. Louie, M. Walther, and K. Pacak

JCO Sep 1 2003: 3369–3371. [Full Text] [PDF]

Unusual Locations of Involvement by Malignancies: CASE 3. GASTRIC SIGNET RING CARCINOMA PRESENTING AS A DIFFUSE THIGH MASS

Geetha N. Varma, Janet S. Winston, Hank C. Hill, John F. Gibbs, Gary M. Proulx, Brian E. McGrath, and Milind M. Javle

JCO Sep 1 2003: 3371–3373. [Full Text] [PDF]

Unusual Locations of Involvement by Malignancies: CASE 4. BILATERAL HYPOPYON HERALDING CNS RELAPSE OF CUTANEOUS NATURAL KILLER CELL LYMPHOMA

Charmaine Hon, Alvin K.H. Kwok, Tony W.H. Shek, and Wing Y. Au

JCO Sep 1 2003: 3373–3374. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Direct Drug Advertising to Consumers: When Pharma Plays Doctor

James E. Hannigan

JCO Sep 1 2003: 3375. [Full Text] [PDF]

Use of Fear-Appeal Techniques in the Design of Tailored Cancer Risk Communication Messages: Implications for Healthcare Providers

Kevin M. Sweet, Sharla K. Willis, Sato Ashida, and Judith A. Westman

JCO Sep 1 2003: 3375-a–3376. [Full Text] [PDF]

Treatment for Asymptomatic Anthracycline-Induced Cardiac Dysfunction in Childhood Cancer Survivors: The Need for Evidence

E.C. van Dalen, H.J.H. van der Pal, C. van den Bos, H.N. Caron, and L.C.M. Kremer

JCO Sep 1 2003: 3377. [Full Text] [PDF]

In Reply:

Steven E. Lipshultz, Stuart R. Lipsitz, Stephen E. Sallan, Richard D. Gelber, and Steven D. Colan

JCO Sep 1 2003: 3377-a–3378. [Full Text] [PDF]

Baseline Heart Rate–Corrected QT and Eligibility for Clinical Trials in Oncology

Mary Varterasian, Mark Meyer, Howard Fingert, Diane Radlowski, Peggy Asbury, Xiaofeng Zhou, and Diane Healey

JCO Sep 1 2003: 3378–3379. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.